Dr. Alessandro Brunelli is a Consultant Thoracic Surgeon and Honorary Clinical Associate Professor at the Department of Thoracic Surgery, St. James’s University Hospital, in Leeds, UK.
He was the former vice-Director of the Division of Thoracic Surgery and Head of Section of Minimally Invasive Thoracic Surgery in Ancona, Italy, where he worked for more than 15 years.
Dr. Brunelli is the current President Elect and Secretary General of the European Society of Thoracic Surgeons (ESTS). He is member of the ESTS Board of Directors since 2008.
He has been the Director of the ESTS Database from 2008 to 2012 and is a member of the Educational Committee and Faculty of the ESTS School of Thoracic Surgery.
Dr. Brunelli is leading the European Institutional Accreditation program.
He is a member of the Thoracic Oncology and Thoracic Surgery HERMES task forces organized by the European Respiratory Society to standardize education in thoracic oncology across Europe.
He is the Author of more than 280 scientific papers published in peer-reviewed impact factored scientific journals with a personal impact factor of 1300 and H-index of 45.
He is a member of the Editorial Board of the Annals of Thoracic Surgery and of the Journal of Thoracic and Cardiovascular Surgery.
Dr. Brunelli is the former co-Chair of the European Respiratory Society/European Society of Thoracic Surgeons joint task force appointed to develop guidelines for the selection of patients for lung cancer radical treatment and is the lead author of the Physiologic Chapter of the third edition of the American College of Chest Physicians guidelines for diagnosis and management of Lung Cancer.
He is the co-chair of the European guidelines of structure and qualification of general thoracic surgery.
His main professional and scientific interests focus on minimally invasive thoracic surgery, quality of care, risk stratification and modeling, patient reported outcomes and health economics.
Selected publications from PubMed
Corrigendum to "European experience on oncological outcomes of patients with early stage non-small cell lung cancer and any prior cancer following lobectomy or segmentectomy" [Lung Cancer J. 217 (2026) 109410].
Lula LJ, Costa R, Huang L, Rushwan A, Domjan M, Franssen AJPM, Weedle R, Marinucci BT, Barreda CF, Jasovic C, Whooley J, Matache RS, Özgür EG, Ryan R, Young V, Tahiri M, Fernandes P, Rendina EA, Bekiroglu N, de Loos ER, Jimenez M, Savu C, Bolca C, Stupnik T, Fitzmaurice GJ, D'Andrilli A, Brunelli A, Petersen RH
Lung Cancer. 2026 Aug;218:109511 doi: 10.1016/j.lungcan.2026.109511.
Corrigendum to "European experience on oncological outcomes of patients with early-stage non-small cell lung cancer and any prior cancer following lobectomy or segmentectomy" Published in [Lung Cancer https://doi.org/10.1016/j.lungcan.2026.109410].
Lula LJ, Costa R, Huang L, Rushwan A, Domjan M, Franssen AJPM, Weedle R, Marinucci BT, Barreda CF, Jasovic C, Whooley J, Matache RS, Özgür EG, Ryan R, Young V, Tahiri M, Fernandes P, Rendina EA, Bekiroglu N, de Loos ER, Jimenez M, Savu C, Bolca C, Stupnik T, Fitzmaurice GJ, D'Andrilli A, Brunelli A, Petersen RH
Lung Cancer. 2026 Aug;218:109508 doi: 10.1016/j.lungcan.2026.109508.
European analysis of patients with early-stage lung adenocarcinoma and invasive pathologic features who underwent lobectomy versus segmentectomy.
Lula LJ, Costa R, Franssen AJPM, Huang L, Özgür EG, Barreda CF, Domjan M, Weedle R, Jasovic C, Trabalza Marinucci B, Rebei M, Ghasemi K, Moreira AL, Ryan R, Bekiroglu GN, Young V, Gomez T, de Loos ER, Fitzmaurice GJ, Bennett KE, Mancini M, Varela G, Savu C, Mariolo AV, Bunn P, Stupnik T, Furak J, D'Andrilli A, Jimenez M, Cerfolio R, Bolca C, Brunelli A, Rami-Porta R, Petersen RH, Rendina EA
J Thorac Cardiovasc Surg. 2026 Aug;172(2):413-421.e4 doi: 10.1016/j.jtcvs.2026.04.011.
European experience on oncological outcomes of patients with early-stage non-small cell lung cancer and any prior cancer following lobectomy or segmentectomy.
Lula LJ, Costa R, Huang L, Rushwan A, Domjan M, Franssen AJPM, Weedle R, Trabalza Marinucci B, Barreda CF, Jasovic C, Whooley J, Matache RS, Özgür EG, Ryan R, Young V, Tahiri M, Fernandes P, Rendina EA, Bekiroglu N, de Loos ER, Jimenez M, Savu C, Bolca C, Stupnik T, Fitzmaurice GJ, D'Andrilli A, Brunelli A, Petersen RH
Lung Cancer. 2026 Jul;217:109410 doi: 10.1016/j.lungcan.2026.109410.
Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration.
Dingemans AC, Opitz I, Brunelli A, Remon J, Hendriks LEL, Edwards J, Faivre-Finn C, Reguart N, Smit EF, Levy A, Sanchez-Lorente D, Trujillo JC, Filippi AR, Stathopoulos K, Blum TG, Guckenberger M, Popat S, De Angelis R, Hofman P, von der Thüsen J, Hartemink KJ, Petersen RH, Ruffini E, Dickhoff C, Houda I, Prisciandaro E, De Ruysscher D, Derks J, Bahce I, Mariolo A, Besse B, Xenophontos E, Giaj Levra N, van Schil P, Brandão M, Berghmans T
Lancet Respir Med. 2026 May;14(5):453-462 doi: 10.1016/S2213-2600(26)00051-2.
Since the late 20th century, Chinese medicine has developed rapidly in comparison to the rest of the world, being China one of the countries which have made more significant advances in medical research and treatments. Aiming to provide a comprehensive, in-depth look at how Chinese medicine is practiced and examine its impact on global health, we proudly introduce Meet the Institutions, as part of the Healing in China series, which gives you access to the best centers of excellence in China, and the opportunity to collaborate with these hospitals and participate in activities and projects organized by them. In this event, AIS Channel specially invites top thoracic surgery experts from China, the United Kingdom and the United States to share academic insights on advances in thoracic cancer surgery. This event features medical presentations, operation videos, and interactive discussions to enhance surgical skills and improve global standards in this field.
With Johnson & Johnson MedTech
Published
Jul 2023
Since the late 20th century, Chinese medicine has developed rapidly in comparison to the rest of the world, being China one of the countries which have made more significant advances in medical research and treatments. Aiming to provide a comprehensive, in-depth look at how Chinese medicine is practiced and examine its impact on global health, we are proud to introduce Meet the Masters, as part of the Healing in China series, which brings together the best Chinese KOLs and top surgeons from other regions of the world to guide you through their surgeries and transfer years of knowledge. In this event, AIS Channel specially invites top thoracic surgery experts from China, the United Kingdom and the United States to share academic insights on lobectomy after neoadjuvant therapy. This event features operation videos, case sharing, and interactive discussions to enhance surgical skills and improve global standards in this field.
With Johnson & Johnson MedTech
Published
Jun 2023
In recent years, China's thoracic surgery technology has developed rapidly, entering the era of minimal invasive precision and committed to promoting the standardization and precision of thoracic surgery.
With Johnson & Johnson MedTech
Published
Feb 2022
Help your network discover Dr. Alessandro Brunelli's clinical expertise.
